|
|
Post by rrtzmd on Nov 7, 2015 12:16:51 GMT -5
If that is your logic, why wouldn't Sanofi blame something that they have no financial interest in? To suggest that they would shift the blame to one of their other products, Afrezza, rather than a myriad of other possibilities would suggest that you either feel Sanofi is stupid, or purposely trying to undermine Afrezza. Quite an interesting proposal. "...why wouldn't Sanofi blame something that they have no financial interest in..." -- indeed, why wouldn't they! If something was available that made sense and in which they had no financial interest, that would certainly be the most logical thing. The next best might be a product in which they have only a 65% interest and which they have recently been blaming for their company's poor performance last quarter. Regardless, at this point, it no longer matters since -- as I keep pointing out -- the investigators will be able to manage the diabetes with any agents they desire, and, consequently, it's unlikely that any of the diabetes drugs will get blamed for any failure. |
|
|
|
Post by jpg on Nov 7, 2015 12:49:21 GMT -5
rrtz
You are reaching and contradicting yourself so much that it becomes difficult and just to time consuming to counter your arguments. It's hard to argue against wild conspiracy theories that pretend to know the 'deep down evil motivations' of trial designers. You are making 'out there' guesses about future intentions (that I have rarely seen any drug trail designers make) on topics you yourself admit to not knowing or understanding. Not certain why you harp on this topic? Drop it.
|
|
|
|
Post by centrn on Nov 7, 2015 12:53:56 GMT -5
Right, so they could blame the patients, other types of medication, other medical problems, poor study design, etc., but you think they would choose to blame one of their other products, Afrezza. That really makes great sense! LOL . Ya, its great know where you are coming from.
|
|
|
|
Post by rrtzmd on Nov 7, 2015 22:02:14 GMT -5
rrtz You are reaching and contradicting yourself so much that it becomes difficult and just to time consuming to counter your arguments. It's hard to argue against wild conspiracy theories that pretend to know the 'deep down evil motivations' of trial designers. You are making 'out there' guesses about future intentions (that I have rarely seen any drug trail designers make) on topics you yourself admit to not knowing or understanding. Not certain why you harp on this topic? Drop it. "Drop it." Well, I'd love to, but then someone turns around and claims I'm presenting "wild conspiracy theories" and I feel compelled to ask "where?" And I'm still waiting for you to provide some of the "many inconsistencies" you claim to have found. Not to mention where I am supposedly "contradicting" myself. |
|
|
|
Post by rrtzmd on Nov 7, 2015 22:13:15 GMT -5
Right, so they could blame the patients, other types of medication, other medical problems, poor study design, etc., but you think they would choose to blame one of their other products, Afrezza. That really makes great sense! LOL . Ya, its great know where you are coming from. "...think they would choose to blame one of their other products, Afrezza." I said no such thing. As I have now said at least 3-4 times, companies almost invariably look for excuses for why a trial fails and that includes shifting the blame away from the drug as much as possible. There are many candidates to choose from and those include other drugs in the study. However, as I have said several times now, my initial assessment was in a previous thread and was based upon a misunderstanding, where I thought afrezza had been chosen to be the only available prandial insulin. I now recognize that it is just one of the many drugs the investigators may use to treat the subjects' diabetes, and SNY would not likely attempt to to single out any particular drug to blame for any shortcomings in the results. |
|
|
|
Post by mssciguy on Nov 7, 2015 22:20:55 GMT -5
what is this thread about? Very hard to follow.
|
|
|
|
Post by blindhog1 on Nov 7, 2015 22:27:03 GMT -5
what is this thread about? Very hard to follow. It's gotten our of hand. Don't worry that these posters have gotten lost in the BS. The bottom line is:
Friday, Sanofi told whoever would listen that they were going to slim down and kick butt. Afrezza is part of that butt kicking.  |
|
|
|
Post by mnholdem on Nov 7, 2015 22:36:00 GMT -5
There are other threads that cover the Sanofi roadmap presentation. This thread has meandered somewhere else.
Time to lock it.
|
|
